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Follicular Dendritic Cell Sarcoma of the
Abdomen: the Imaging Findings
Follicular dendritic cell sarcoma is a rare neoplasm that originates from follicular
dendritic cells in lymphoid follicles. This disease usually involves the lymph
nodes, and especially the head and neck area. Rarely, extranodal sites may be
affected, including tonsil, the oral cavity, liver, spleen and the gastrointestinal
tract. We report here on the imaging findings of follicular dendritic cell sarcoma of
the abdomen that involved the retroperitoneal lymph nodes and colon. It shows
as a well-defined, enhancing homogenous mass with internal necrosis and
regional lymphadenopathy.
ollicular dendritic cells are found in primary and secondary lymphoid
follicles. These cells participate in the immune system by retaining and
presenting antigens for B cells and they also stimulate B cell proliferation
and differentiation (1). Follicular dendritic cell sarcoma is a rare neoplasm that arises
from these follicular dendritic cells. The disorder was originally described in 1986 in a
report on a non-lymphomatous primary lymph node malignancy (2). Several patholog-
ical and clinical studies concerned with follicular dendritic cell sarcoma have been
reported. However, to the best of our knowledge, follicular dendritic cell sarcoma of
the abdomen has not yet been described with a focus on the imaging findings. We
report here on two cases of follicular dendritic cell sarcoma of the abdomen that
involved the retroperitoneal lymph nodes and the colon, respectively. We also review
the relevant medical literature.
CASE REPORTS
Case 1
A 69-year-old man presented with a 2-month history of intermittent epigastric pain.
At the time of presentation, the patient had hypertension that was controlled with
medication, and he had no other remarkable past medical history. The physical
examination and laboratory tests were unremarkable.
After admission, the patient underwent an upper gastroduodenal endoscopy
examination and the result was normal. We then performed ultrasonography (US) and
computed tomography (CT) examinations to further evaluate the abdominal pain.
Based on the US findings, a large well-defined anechoic mass was identified and it was
located in the posterior aspect of the splenic vein. The lesion was seen with posterior
acoustic enhancement that suggested the presence of a cystic or necrotic mass (Fig.
1A). Helical CT was performed using a multidetector-row CT (MDCT) scanner
(LightSpeed VCT; GE Healthcare; Milwaukee, WI) with 64 detectors. The abdominal
CT axial and coronal images (Fig. 1B, C) showed an approximately 5 cm sized, well-
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Fdefined, necrotic mass with an even peripheral wall in the
retroperitoneal area. The mass was located between the
left renal vein and the splenic vein and the mass
compressed the adjacent pancreas without evidence of
direct invasion. There was no calcification detected in the
mass. Several abnormal enlarged lymph nodes in the left
gastric area were also noted. Based on these imaging
findings, metastatic lymph nodes, tuberculosis lymphadeni-
tis and an unusual form of Castleman’s disease were
considered in the differential diagnosis. The main necrotic
mass and abnormal enlarged lymph nodes were removed
by surgical excision. On a gross specimen, the mass showed
extensive internal necrosis that correlated to the image
findings seen on US (Fig. 1D). Spindle to ovoid cells that
made up fascicles were identified on a light microscopic
examination of the resected mass and lymph nodes. The
tumor cells had slightly eosinophilic plump cytoplasm with
an indistinct cell border and small nuclei (Fig. 1E). After
immunohistochemical staining, the tumor cells showed
focal positivity for CD 21 and CD 35. These findings were
consistent with a follicular dendritic cell sarcoma.
Case 2
A 52-year-old woman presented with hematochezia and
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Fig. 1. Follicular dendritic cell sarcoma in 69-year-old man.
A. Abdominal ultrasonography shows 5 cm sized, well-defined anechoic mass (white arrows) that was located in posterior aspect of
pancreas (P) with mild mass effect. Mass shows posterior acoustic enhancement that represents necrotic lesion.
B. Axial CT scan shows well-defined necrotic mass with thin peripheral wall in retroperitoneal area (white arrows). Lesion shows mass
effect on adjacent pancreas and splenic vein, but there was no evidence of direct invasion.
C. Coronal reconstruction CT image shows several enlarged lymph nodes (black arrows) around cystic mass (white arrows).
D. Gross specimen shows central whitish-yellow color that microscopically demonstrates extensive internal necrosis.
E. Microscopic examination of solid component of mass reveals bundles of ovoid to spindle cells with pinkish cytoplasm (Hematoxylin &
Eosin staining, ×100).
CD Edyspepsia. The symptoms had developed two weeks prior
to the patient’s presentation to a local clinic and then
colonoscopy was performed at that clinic. According to the
colonoscopic findings, an approximate 12 cm intraluminal
fungating mass was detected in the descending colon. A
gastrointestinal stromal tumor (GIST) in the colon was
initially suspected. The patient was transferred to our
hospital for further evaluation and management. All of the
laboratory findings, including the levels of tumor markers
(CA 19-9 and carcinoembryonic antigen), were unremark-
able except for a low hemoglobin level (10.5 g/dL). The
hemoglobin level was slightly decreased due to
hematochezia.
A CT scan (Sensation 64; Siemens Healthcare, Erlangen,
Germany) was performed for surgical planning and the
multiplanar reconstruction images were obtained. On a
pre-enhanced CT scan, the mass showed multiple foci of
irregular and dense calcifications in the central portion
(Fig. 2A). The axial and coronal post-enhanced CT images
(Fig. 2B, C) showed that the mass was well-defined, with a
size of 12 cm at the longest diameter. The mass was seen
with two homogenously enhancing components and a
lobulated margin. The mass was located in the mid-
descending colon and the mass was composed of intralumi-
nal and extraluminal components. The intraluminal
component showed less enhancement than did the extralu-
minal component. There was no evidence of adjacent
organ invasion as seen the coronal images, but multiple
enlarged lymph nodes were noted around the mesocolon
and inferior mesenteric vessels. Based on these imaging
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Fig. 2. Follicular dendritic cell sarcoma in 52-year-old woman.
A. Pre-contrast axial CT image shows multiple foci of irregular and dense calcifications in mass (white arrows).
B. Post-contrast axial CT image shows well-defined large mass in mid-descending colon. Mass is composed of intraluminal (white arrow)
and extraluminal (black arrow) components. Intraluminal component is less enhanced than extraluminal component.
C. Coronal reconstruction CT image shows several enlarged regional lymph nodes (black arrows) around mass (white arrow).
D. Gross specimen shows intraluminal component with relatively dull yellow color (white arrow) and non-necrotic area of extraluminal
component (black arrow) with pink-tan color. Several enlarged pericolonic lymph nodes (asterisks) are noted.
E. Immunohistochemical staining for CD35 demonstrates positive cytoplasmic expression (×400).
CD Efindings, we suspected that the mass was a malignant GIST
or an unusual sarcoma that arose from the descending
colon with metastatic lymph nodes for the differential
diagnosis. The patient then underwent a left hemicolec-
tomy. During surgery, a well-defined mass that measured
12×10 cm was identified in the mid-descending colon.
There was direct focal invasion of the left lateral parietal
peritoneum by the mass, but the overall margin of the
tumor was well-defined. On a gross specimen, the mass
showed a relatively dull yellow color with some portions
of necrosis in the intra-luminal component, and the non-
necrotic extra-luminal component had a pink-tan, solid
appearance (Fig. 2D). On a light microscopic examination,
the cellular component of the mass was composed of
plump spindle cells with open chromatin and small nuclei.
These cells had a rather bland appearance and any mitotic
figures were not identified. Sclerotic bundles with multifo-
cal calcifications, several lymphocytes, plasma cells and
eosinophils were admixed with foamy macrophages. The
tumor cells showed focal positivity for CD35 (Fig. 2E).
These findings were compatible with a diagnosis of follicu-
lar dendritic cell sarcoma.
DISCUSSION
Follicular dendritic cell sarcoma is a rare neoplasm and it
is a neoplastic proliferation of spindle-shaped to ovoid cells
that demonstrate the morphological and phenotypical
features of follicular dendritic cells. Proliferations of follic-
ular dendritic cells occur in the situation of reactive and
neoplastic conditions (3). The neoplastic cells usually
demonstrate the phenotype of non-neoplastic follicular
dendritic cells. The cells can be positive for one or more
markers as determined with immunohistochemical
staining, and these markers are also found in non-neoplas-
tic follicular dendritic cells. Among these markers,
determining the levels of CD21 and CD35 is helpful for
making the diagnosis of follicular dendritic cell sarcoma
(4). The diagnosis of follicular dendritic cell sarcoma can be
made based on the characteristic ultrastructural or
immunohistochemical findings (5).
Clinically, this neoplasm affects both sexes equally. The
disease occurs over a wide age range from 14 to 77 years
(mean age: 47 years) and this malady typically presents as
a painless, slow growing well-defined mass lesion at the
involved site (5). The predominant site of tumor involve-
ment in most cases is the lymph nodes. Especially, the
disease shows a greater tendency to occur in the head and
neck area, yet this disease is also known to occur in extran-
odal sites such as tonsil, palate, small intestine, mesocolon,
pancreas, liver, mesentery, the abdominal wall and the soft
tissue of the neck (4, 6-10). Various treatment modalities
have been used to treat this tumor, including surgery,
chemotherapy and radiation therapy. Complete surgical
resection should be considered for localized disease. Good
results have been seen for patients who received neo-
adjuvant radiotherapy and chemotherapy. However, no
definite therapeutic approach has demonstrated consistent
efficacy (5). In our first case, local recurrence was detected
on a follow-up CT scan after eight months from the time of
surgery.
Any studies that have focused on demonstrating the
imaging findings of follicular dendritic cell sarcoma are
limited because of the rarity of this tumor. The presence of
this disease has been demonstrated in a few oncological
case reports as a large mass with or without regional
lymphadenopathy in the abdomen (8, 9). In the radiologi-
cal literature, Leipsic et al. (11) first described the CT
findings of a follicular dendritic cell sarcoma of the
mediastinum in 2007. They reported that the tumor was
seen as bulky soft tissue mass with internal calcifications on
a non-enhanced CT scan.
In our study, one case showed a retroperitoneal mass
that represented the nodal type, and the other case
demonstrated colon involvement that represented the
extranodal type. For the case of the nodal type, the
retroperitoneal mass was seen as a well-defined lesion with
central necrosis and regional lymphadenopathy. There was
no calcification or hemorrhage within the mass. The CT
findings were similar to those of metastatic lymphadenopa-
thy, tuberculosis lymphadenitis and an unusual form of
Castleman’s disease (12). Among these diseases,
Castleman’s disease has been found in association with a
follicular dendritic cell sarcoma, which suggests that it may
represent a precursor lesion (13). Thus, it is possible that a
follicular dendritic cell sarcoma of the abdomen will share
the imaging findings of Castleman’s disease in some
respects, and especially for the nodal type. 
In the case of the extranodal type, the colon mass was
seen with coarse internal calcification, and this was unlike
the nodal type. The relatively low enhanced portion of the
intraluminal component, as seen on CT images, showed
several mixtures of necrosis on a pathological examination.
Although the tumor was of a large size, the tumor showed
homogenous enhancement except for the area of necrosis
and it was well-demarcated without CT evidence of
invasion to any adjacent structure. The differentiating
features may be a large area of even internal necrosis and
a well-defined margin in the setting of a large tumor, as
compared with other colonic masses such as a malignant
GIST. Considering these findings, the extranodal type
showed imaging findings that were similar to those of the
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regional lymphadenopathy and homogenous enhancement
with internal necrosis are the CT findings of follicular
dendritic cell sarcoma of the abdomen. Calcification within
the mass is possibly seen in the extranodal type of the
lesion. Further, a follicular dendritic cell sarcoma generally
behaves more like a sarcoma than a lymphoma (14).
Actually, we detected a small area of direct invasion to the
adjacent peritoneum for the case of the colon mass, as was
determined from the pathological examination. 
In this report, we have described the imaging findings of
follicular dendritic cell sarcoma of the abdomen. A follicu-
lar dendritic cell sarcoma of the abdomen manifested as a
discrete, well-enhancing homogenous mass with internal
necrosis and regional lymphadenopathy. Internal calcifica-
tion may also be seen. Based on these imaging findings,
although it is a very unusual tumor, a follicular dendritic
cell sarcoma should be considered in the differential
diagnosis of a retroperitoneal and colonic mass. 
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